Terms: = Leukemia AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
164 results:
1. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
Chen Y; Qiu X; Liu R
BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
[TBL] [Abstract] [Full Text] [Related]
2. UBE2C promotes the proliferation of acute myeloid leukemia cells through pi3k/AKT activation.
Wang L; Zhao S; Wang Y; Liu J; Wang X
BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
[TBL] [Abstract] [Full Text] [Related]
3. TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database.
Pan X; Chang Y; Ruan G; Zhou S; Jiang H; Jiang Q; Huang X; Zhao XS
Clin Exp Med; 2024 Feb; 24(1):35. PubMed ID: 38349460
[TBL] [Abstract] [Full Text] [Related]
4. pi3kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway.
Gu H; Chen C; Hou ZS; He XD; Xie S; Ni J; Qian C; Cheng X; Jiang T; Yang C; Roberts TM; Zheng J; Varner JA; Armstrong SA; Zhao JJ
Blood; 2024 May; 143(19):1965-1979. PubMed ID: 38271660
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of pi3k-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells.
Şansaçar M; Sağır H; Gencer Akçok EB
Med Oncol; 2023 Dec; 41(1):31. PubMed ID: 38148433
[TBL] [Abstract] [Full Text] [Related]
6. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
7. AXL - a new player in resistance to HER2 blockade.
Adam-Artigues A; Arenas EJ; Arribas J; Prat A; Cejalvo JM
Cancer Treat Rev; 2023 Dec; 121():102639. PubMed ID: 37864955
[TBL] [Abstract] [Full Text] [Related]
8. XBP1 promotes NRAS
Salimi A; Schemionek-Reinders M; Huber M; Vieri M; Patterson JB; Alten J; Brümmendorf TH; Kharabi Masouleh B; Appelmann I
J Cell Mol Med; 2023 Nov; 27(21):3363-3377. PubMed ID: 37753803
[TBL] [Abstract] [Full Text] [Related]
9. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
[TBL] [Abstract] [Full Text] [Related]
10. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia.
Dobish KK; Wittorf KJ; Swenson SA; Bean DC; Gavile CM; Woods NT; Ghosal G; Hyde RK; Buckley SM
Leukemia; 2023 Nov; 37(11):2197-2208. PubMed ID: 37689825
[TBL] [Abstract] [Full Text] [Related]
11. Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia.
Xie C; Zhou H; Qin D; Zheng H; Tang Y; Li W; Zhou J; Liu L; Yu X; Duan H; Zhou Y; Li Z; Fang Z; Luo Y; Carter BZ; Xu B; Zha J
Cell Death Dis; 2023 Aug; 14(8):573. PubMed ID: 37644011
[TBL] [Abstract] [Full Text] [Related]
12. Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid leukemia (AML).
Ganji A; Khosravi M; Mosayebi G; Gholami M; Ghazavi A; Keshavarzian N; Sayyadi M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2271-2277. PubMed ID: 37505756
[TBL] [Abstract] [Full Text] [Related]
13. SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses leukemia Growth in a T-ALL Xenotransplantation Mouse Model.
Ehm P; Rietow R; Wegner W; Bußmann L; Kriegs M; Dierck K; Horn S; Streichert T; Horstmann M; Jücker M
Cells; 2023 Jul; 12(13):. PubMed ID: 37443832
[TBL] [Abstract] [Full Text] [Related]
14. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.
Villa-Morales M; Pérez-Gómez L; Pérez-Gómez E; López-Nieva P; Fernández-Navarro P; Santos J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373496
[TBL] [Abstract] [Full Text] [Related]
15. Improved efficacy of quizartinib in combination therapy with pi3k inhibition in primary FLT3-ITD AML cells.
Darici S; Jørgensen HG; Huang X; Serafin V; Antolini L; Barozzi P; Luppi M; Forghieri F; Marmiroli S; Zavatti M
Adv Biol Regul; 2023 Aug; 89():100974. PubMed ID: 37245251
[TBL] [Abstract] [Full Text] [Related]
16. pi3k/ c-Myc/AFF4 axis promotes pancreatic tumorigenesis through fueling nucleotide metabolism.
Ni C; Liu W; Zheng K; Guo S; Song B; Jing W; Li G; Li B; Ni C; Shi K; Jin G; Yu G
Int J Biol Sci; 2023; 19(6):1968-1982. PubMed ID: 37063434
[TBL] [Abstract] [Full Text] [Related]
17. Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the pi3kinase pathway.
Palam LR; Ramdas B; Pickerell K; Pasupuleti SK; Kanumuri R; Cesarano A; Szymanski M; Selman B; Dave UP; Sandusky G; Perna F; Paczesny S; Kapur R
JCI Insight; 2023 May; 8(9):. PubMed ID: 36976647
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the pi3k/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract] [Full Text] [Related]
19. A rare case of Klippel-Trenaunay syndrome presenting with chronic myeloid leukemia.
Coşkun Ç; Aksu T; Gümrük F; Ünal Ş
Turk J Pediatr; 2023; 65(1):124-128. PubMed ID: 36866992
[TBL] [Abstract] [Full Text] [Related]
20. MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the pi3k/AKT/SOX2 Axis.
Yang Y; Qiu R; Weng Q; Xu Z; Song J; Zhao S; Meng M; Zhang D; Kong C; Wang H; Xu M; Zhao Z; Ji J
Cancer Res Treat; 2023 Jul; 55(3):778-803. PubMed ID: 36701842
[TBL] [Abstract] [Full Text] [Related]
[Next]